Immune Booster

Immune Booster

This study is currently inactive


The purpose of this study is to determine if the new medication can prevent symptomatic respiratory illness in patients 65 and over.

Study Length:

20 weeks with 8 office visits; compensation of $450.

Study Procedure: 

Physical Exam, heart & respiratory rate, ECG, blood work, labs, urinalysis.


  • Male or females 65
  • Patients who require no or minimal assistance with self-care and daily activities
  • Patient who are non-smokers -or- quit smoking 1 year prior to screening
  • No presence of any other clinically significant lung disease
  • Special focus on patients with asthma, heart failure, 85 and older

Participate in a Study

Submit the form and a clinical study expert will get in touch with you.

Want to know more about our clinical trials?

Leave a Reply